Financhill
Buy
58

TRVI Quote, Financials, Valuation and Earnings

Last price:
$6.19
Seasonality move :
40.55%
Day range:
$6.19 - $6.78
52-week range:
$2.30 - $7.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.33x
Volume:
892.7K
Avg. volume:
1.4M
1-year change:
111.99%
Market cap:
$629.8M
Revenue:
--
EPS (TTM):
-$0.45

TRVI Analysts' Consensus Rating

The 7 analysts providing 12-month price projections for Trevi Therapeutics shares anticipate an average target of $19.72, ranging from a low estimate of $11.00 to a high estimate of $29.00. This average target implies a growth of 218.61% compared to the current stock price of $6.19.

Consensus Price Target

$19.72

Highest Price Target

$29.00

Lowest Price Target

$11.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 6 7 7

Hold 0 0 0

Sell 0 0 0
Consensus Buy Buy Buy

TRVI Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Bloom Energy Stock Go?
How High Will Bloom Energy Stock Go?

Bloom Energy (NYSE:BE) has seen its shares surge by more…

Is Acuity a Good Stock to Buy Now?
Is Acuity a Good Stock to Buy Now?

Acuity Brands (NYSE:AYI) is an industrial company specializing in lighting.…

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
74
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
71
NUTX alert for May 15

Nutex Health [NUTX] is up 9.76% over the past day.

Buy
81
EXEL alert for May 15

Exelixis [EXEL] is up 3.67% over the past day.

Sell
29
GLBE alert for May 15

Global E Online [GLBE] is down 3.44% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock